Molecular and Functional Studies of Tyrosinase Variants Among Indian Oculocutaneous Albinism Type 1 Patients  by Chaki, Moumita et al.
Magerl M, Tobin DJ, Muller-Rover S et al. (2001)
Patterns of proliferation and apoptosis during
murine hair follicle morphogenesis. J Invest
Dermatol 116:947–55
Mott JD, Werb Z (2004) Regulation of matrix
biology by matrix metalloproteinases. Curr
Opin Cell Biol 16:558–64
Nothnick W (2008) Regulation of uterine
matrix metalloproteinase-9 and the role
of microRNAs. Semin Reprod Med
26:494
Obana N, Ito M, Kobayashi T et al. (1996)
Collagenolytic activities with differentiation
of the cultured cells from the murine hair
apparatus. J Dermatol Sci 13:83–6
Paus R, Krejci-Papa N, Li L et al. (1994)
Correlation of proteolytic activities of organ
cultured intact mouse skin with defined hair
cycle stages. J Dermatol Sci 7:202–9
Pinkus H (1958) Embryology of hair. In: The
Biology of Hair Growth (Montagna W, Ellis
RA, eds), New York: Academic Press, 1–32
Schmidt-Ullrich R, Paus R (2005) Molecular
principles of hair follicle induction and
morphogenesis. Bioessays 27:247–61
Sharov AA, Weiner L, Sharova TY et al. (2003)
Noggin overexpression inhibits eyelid open-
ing by altering epidermal apoptosis and
differentiation. EMBO J 22:2992–3003
Vu TH, Shipley JM, Bergers G et al. (1998)
MMP-9/gelatinase B is a key regulator of
growth plate angiogenesis and apoptosis of
hypertrophic chondrocytes. Cell 93:411–22
Molecular and Functional Studies of Tyrosinase Variants
Among Indian Oculocutaneous Albinism Type 1 Patients
Journal of Investigative Dermatology (2011) 131, 260–262; doi:10.1038/jid.2010.274; published online 23 September 2010
TO THE EDITOR
Oculocutaneous albinism (OCA) refers
to a heterogeneous group of autosomal
recessive disorders that are charac-
terized by hypopigmentation of the
skin, hair, and eyes and associated with
developmental eye defects. Because
OCA is a major cause of childhood
blindness in India, containing it is
crucial. Methods of doing so include
identification of molecular lesions,
detection of carriers, and premarriage
genetic counseling; however, the avail-
able genetic information is limited.
We previously reported that OCA1,
which is caused by defects in tyrosinase
(TYR, 11q14-q21, MIM606933), is the
major OCA subtype in India (Chaki
et al., 2006). Here, we report the
characterization of 11 unrelated OCA1
patients bearing nine different TYR
mutations (c.655G4A, p.Glu219Lys;
c.832C4T, p.Arg278Stop; c.976C4T,
p.Gln326Stop; c.1037G4T, p.Gly346Val;
c.1265G4A, p.Arg422Gln; c.1379delTT;
Deletion 30TYR; c.530T4A, p.Val177Asp;
c.1299C4G, p.Tyr433Stop) (Supple-
mentary Table S1 online). To our
knowledge, the last two of these were
previously unreported. Both mutations
were identified in 10 patients, but in
one patient a single TYR mutation
was detected despite analyzing the
entire coding region, untranslated
regions, the putative locus control
region core, and the promoter contain-
ing a complex GA-repeat having the
potential to induce DNA secondary
structure (Ray et al., 2007). In addition,
no causal variant was identified in
other known OCA loci in this patient
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Figure 1. Functional characterization of mutant TYRs revealed ER retention as the cause of the loss of
enzyme function. (a) The enzymatic activity (tyrosinase hydroxylase and DOPA oxidase) of wild-type
(WT) TYR is represented as 100%, and all the mutants showed complete lack of enzyme activity.
(b) On zymogram assay, the DOPA-melanin band is visible only for WT protein. (c) The immunoblots
of EndoH-untreated (EndoH) and -treated (þ EndoH) cell lysates for WT and mutant TYRs. Only
EndoH-treated WT TYR shows a distinct EndoH-resistant form, as represented by the lower-mobility
band (marked by an arrow) along with an EndoH-sensitive higher-mobility band, whereas all the
mutants show only the EndoH-sensitive higher-mobility band. DOPA, L-3,4-dihydroxyphenylalanine;
EndoH, endoglycosidase H; ER, endoplasmic reticulum; TYR, tyrosinase.
Abbreviations: EndoH, endoglycosidase H; ER, endoplasmic reticulum; L-DOPA, L-3,4-
dihydroxyphenylalanine; OCA, oculocutaneous albinism; TYR, tyrosinase
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(Sengupta et al., 2010). Therefore,
including the previously identified
cases, the frequency of OCA1 with
uncharacterized mutations is 8.3%
(3/36) in our OCA1 patient cohort,
almost twice that of a recent report
from China (4.5%, Wei et al., 2010). It
is worth noting that we detected two
OCA1 patients homozygous for the most
prevalent mutation in India (p.Arg278-
Stop) but harboring different haplo-
types than one reported previously
(Chaki et al., 2005), suggesting de novo
occurrence of the mutation influenced
by CpG sequence. Our overall data
suggested that, among the OCA-affected
Indians, the frequency of OCA1 subtype
is B61% (36/59 unrelated families).
All the TYR defects reported from Indian
OCA1 cases are listed in Supplementary
Table S1 online.
Because our study was based mostly
on small families (sometimes only the
proband sample was available), an
unequivocal causal relationship of
the putative mutations with the dis-
order cannot be argued very strongly.
Although in/del and nonsense changes
are predicted to translate to aberrant
and/or truncated proteins, nonsynony-
mous changes remain open to specula-
tion without functional clarification.
Hence, we characterized six missense
mutations (p.Asp42Asn, p.Cys91Ser,
p.Val177Asp, p.Glu219Lys, p.Gly372Arg,
p.Gly419Arg) identified in our OCA1
cohort. Because p.Gly346Val was a
recent finding and p.Arg422Gln had
already been validated as a tempera-
ture-sensitive mutation (King et al.,
1991), those were excluded from our
study. Notably, TYR, the most impor-
tant protein in melanogenesis, catalyzes
the first two rate-limiting steps: hydro-
xylation of L-tyrosine and oxidation of
L-DOPA (L-3,4-dihydroxyphenylalanine).
Relevant enzyme assays revealed that
none of the mutants had any tyrosine
hydroxylase and DOPA oxidase acti-
vities in comparison with the wild-type
TYR (Figure 1a and b). Thus, it was
evident that OCA1 individuals with
these mutations lacked functional TYRs,
leading to melanin deficiency and
consequently to OCA1 pathogenesis. It
is likely that these mutations lead to
either immature, mislocalized proteins or
fully processed, but catalytically inactive,
proteins. To resolve this, subcellular
localization of the mutant proteins was
assessed through immunofluorescence
study with calnexin (an endoplasmic
reticulum (ER) marker) and a-1,2-
mannosidase II (Golgi marker), which
demonstrated that all the mutants colo-
calized with calnexin but not with a-1,2-
mannosidase II, indicating ER retention
of the mutant TYRs as the cause of
pathogenesis (data not shown). To
confirm this observation, an endoglyco-
sidase H (EndoH) assay was performed
with the wild-type and mutant TYRs,
followed by western blot analysis
(Figure 1c). EndoH can cleave TYRs in
high-mannose forms, characteristic of
ER processing, but not in those with
complex carbohydrate modifications
(attained in Golgi). Our study revealed
that, unlike the wild-type TYR, all
the mutant proteins were immature
ER-retained species, as suggested by
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Figure 2. Distribution of rs1042602 (c.575C4A, p.Ser192Tyr) in different population groups and an estimate of its enzymatic activity. (a) The distribution
of the derived allele A and ancestral allele C of tyrosinase among Indians. The Indian population comprises 55 ethnic groups representing 4 major
linguistic groups—Indo-European (IE), Dravidian (DR), Austro-Asiatic (AA), and Tibeto-Burman (TB)—and the outgroup (OG). Panel b shows the same for
the HapMap populations. These populations are designated CEU, TSI, MEX, CHB, JPT, GIH, YRI and ASW. Details are available at the HapMap website
(http://snp.cshl.org/cgi-perl/gbrowse/hapmap27_B36/). (c) Relative enzyme activities (tyrosine hydroxylase (TH) and DOPA oxidase (DO)) of TYR, encoded
by both Ser192 and Tyr192 alleles. DOPA, L-3,4-dihydroxyphenylalanine; TYR, tyrosinase.
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the presence of only the higher-mobility
band in the gel (Figure 1c). As expected
in the dynamic milieu of a living cell,
a fraction of wild-type TYR was always
being processed in the ER. Thus, the
EndoH-treated wild-type TYR showed
two distinct bands; the higher one
corresponding to the mature protein
(hence, EndoH resistant) and the
lower one comigrating with the mutant
TYRs, signifying its immature status
(that is, EndoH sensitive). Our observa-
tion corroborates an earlier finding
that OCA1 is an ER-retention disease
(Halaban et al., 2000). Given that the
selected mutations spanned entire TYR
polypeptides, it is likely that ‘‘sorting
failure’’ is the key mechanism of
OCA1 pathogenesis in most missense
mutations. However, it would be inter-
esting to determine whether all missense
mutations cause OCA1 in a similar
manner.
Previously, we identified a TYR
cSNP p.Ser192Tyr (c.575TCT4TAT,
rs1042602, Giebel and Spritz, 1990)
among some OCA1 individuals.
This single-nucleotide polymorphism
has biased distribution among the
HapMap population—the frequency of
the derived allele (Tyr192) is quite high
(0.43–0.51) among populations of Euro-
pean descent, but it was very low or
completely absent among all others. In
addition, it has recently been proposed
to be a risk factor for squamous cell
carcinoma (Nan et al., 2009). We, as a
part of the Indian Genome Variation
Consortium, genotyped p.Ser192Tyr in
1,871 normal healthy Indians, compris-
ing 55 ethnicities belonging to four
linguistic groups representing the over-
all population diversity of India (Indian
Genome Variation Consortium, 2008).
As compared with the Dravidian and
Austro-Asiatic groups, the likely natives
of the Indian subcontinent, Tyr192 was
found to be overrepresented among the
Indo-Europeans (Figure 2a). Notably,
because the 192nd residue is located
within the copper-A catalytic site with
H-bonded His residues at 180, 202, and
211 (Garcı´a-Borro´n and Solano, 2002;
Schweikardt et al., 2007), Ser4Tyr
substitution might perturb the substrate
binding or catalytic property as a result
of steric hindrance. Our functional
study revealed B40% reduced enzy-
matic activity for Tyr192, but further
insight into the molecular event would
require elucidation of the crystal struc-
ture of the protein, which is not yet
available.
Considering that 5–8% residual en-
zyme activity is enough to influence
partial pigmentation in OCA1B patients
(King and Witkop, 1977), it would be
valuable to assess the role, if any, that
Tyr192 plays in pigmentation variation
as reported by genome-wide associa-
tion studies (Stokowski et al., 2007).
It should be noted that none of our
OCA1 individuals with uncharacterized
mutations harbors Tyr192, thereby
preventing us from exploring its role in
OCA1 pathogenesis. Nevertheless, this
information would be useful in future
epidemiological studies pertaining to
the wide variation in skin pigmentation
profiles across India.
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